Page 24 - 中国全科医学2022-30

http://www.chinagp.net E-mail:zgqkyx@chinagp.net.cn ·3733·

·临床热点·争鸣·

妊娠期高血压疾病的降压启动时机

——早期干预降低临床风险

扫描二维码
1
黎娜 ，程文立 2* 查看原文

【摘要】 妊娠高血压疾病（妊高症）是危害妊娠期女性健康及胎儿成长发育的严重不良因素，妊高症在我国妊
娠期女性中的发病率为 6%~8%，随着我国生育政策的放开，孕产妇平均年龄较前增大，超重、肥胖、糖尿病等风险
因素普遍增加，妊高症的潜在风险较突出。在妊高症的诊断标准方面国际上专家的看法保持较为一致，≥ 140/90 mm
Hg 是诊断妊娠高血压的界定值，但妊高症应该何时启动降压治疗，所需的可作为证据的高水平研究较少。近年来各
高血压学术组织对妊娠期女性合并慢性高血压的治疗控制目标值的建议也存在较大争议，各国各学会指南对于妊娠期
高血压的治疗阈值和降压目标值分歧较大。本文就妊高症的危害、何时启动降压进行了详细阐述，同时对妊高症的早
期干预效果及妊高症防治新方法进行分析，旨在为临床妊高症的降压治疗提供参考。
【关键词】 高血压，妊娠性；妊娠高血压；降压，控制性；早期干预
【中图分类号】 R 714.246 【文献标识码】 A DOI：10.12114/j.issn.1007-9572.2022.0517
黎娜，程文立 . 妊娠期高血压疾病的降压启动时机——早期干预降低临床风险［J］. 中国全科医学，2022，25（30）：
3733-3738. ［www.chinagp.net］
LI N，CHENG W L. Timing of antihypertensive initiation in gestational hypertension—early intervention can reduce clinical
risk［J］. Chinese General Practice，2022，25（30）：3733-3738.

Timing of Antihypertensive Initiation in Gestational Hypertension—Early Intervention Can Reducec Clinical Risk LI
1
Na ，CHENG Wenli 2*
1.Second Department of Health Care，China-Japan Friendship Hospital，Beijing 100029，China
2.Hypertension Center，Beijing Anzhen Hospital，Capital Medical University，Beijing 100029，China
*
Corresponding author：CHENG Wenli，Professor；E-mail：chengwenli2000@163.com
【Abstract】 Gestational hypertensionis a serious adverse factor that endangers the health of women during pregnancy
and the growth and development of the fetus. The incidence of gestational hypertension in pregnant women in China is 6% to 8%，
with the liberalization of the fertility policy in China，the average age of pregnant women has increased，and risk factors such
as overweight，obesity，and diabetes have generally increased，the potential risk of gestational hypertension is more prominent

1.100029 北京市，中日友好医院保健二部 2.100029 北京市，首都医科大学附属北京安贞医院高血压中心
*
通信作者：程文立，教授；E-mail：chengwenli2000@163.com
本文数字出版日期：2022-08-11

［18］LIOW M H L，LEE L C，TAN N C K，et al. Personal protective 10.1002/14651858.CD011621.pub4.
equipment training for non-healthcare workers in the COVID-19 ［21］HAEGDORENS F，FRANCK E，SMITH P，et al. Sufficient
pandemic：effectiveness of an evidence-based skills training personal protective equipment training can reduce COVID-19
framework［J］. Infect Dis Health，2022，27（1）：38-48. related symptoms in healthcare workers：a prospective cohort
DOI：10.1016/j.idh.2021.09.040. study［J］. Int J Nurs Stud，2022，126：104132. DOI：
［19］ZANGOUE M，SAFARI H，ROYCE S G，et al. The high level of 10.1016/j.ijnurstu.2021.104132.
adherence to personal protective equipment in health care workers ［22］LI F，JIANG T，SHI T，et al. Factors that affect the duration of
efficiently protects them from COVID-19 infection［J］. Work， wearing disposable personal protective equipment by healthcare
2021，69（4）：1191-1196. DOI：10.3233/WOR-210634 professionals in Wuhan during treatment of COVID-19 patients：an
［20］VERBEEK J H，RAJAMAKI B，IJAZ S，et al. Personal epidemiological study［J］. Nurs Health Sci，2021，23（1）：
protective equipment for preventing highly infectious diseases due 245-254. DOI：10.1111/nhs.12814.
to exposure to contaminated body fluids in healthcare staff［J］. （收稿日期：2022-05-27；修回日期：2022-07-25）
Cochrane Database Syst Rev，2020，4（4）：CD011621. DOI： （本文编辑：鹿飞飞）